Page 36 - GPD-3-3
P. 36

Gene & Protein in Disease                                     Modulating immune response in liver by curcumin



               doi: 10.1172/JCI21593                           46.  Malehmir M, Pfister D, Gallage S, et al. Platelet GPIbα is a
                                                                  mediator and potential interventional target for NASH and
            35.  Zimmermann HW, Bruns T, Weston CJ, et al. Bidirectional
               transendothelial migration of monocytes across hepatic   subsequent liver cancer. Nat Med. 2019;25:641-655.
               sinusoidal endothelium shapes monocyte differentiation      doi: 10.1038/s41591-019-0379-5
               and regulates the balance between immunity and tolerance   47.  Fabregat I, Moreno-Càceres J, Sánchez A,  et al. TGF-β
               in liver. Hepatology. 2016;63(1):233-246.          signalling and liver disease. FEBS J. 2016;283:2219-2232.
               doi: 10.1002/hep.28285                             doi: 10.1111/febs.13665
            36.  Sander LE, Sackett SD, Dierssen U, et al. Hepatic acute-phase   48.  Baiocchini A, Montaldo C, Conigliaro A, et al. Extracellular
               proteins control innate immune responses during infection   matrix molecular remodeling in human liver fibrosis
               by promoting myeloid-derived suppressor cell function.   evolution. PLoS One. 2016;11:e0151736.
               J Exp Med. 2010;207(7):1453-1464.
                                                                  doi: 10.1371/journal.pone.0151736
               doi: 10.1084/jem.20091474
                                                               49.  Tacke F, Zimmermann HW. Macrophage heterogeneity in
            37.  Moshage H. Cytokines and the hepatic acute phase response.   liver injury and fibrosis. J Hepatol. 2014;60:1090-1096.
               J Pathol. 1997;181(3):257-266.
                                                                  doi: 10.1016/j.jhep.2013.12.025
               doi:   10.1002/(SICI)1096-9896(199703)181:3<257:AID-
               PATH756>3.0.CO;2-U                              50.  Karlmark KR, Weiskirchen R, Zimmermann HW,  et al.
                                                                  Hepatic recruitment of the inflammatory Gr1+ monocyte
            38.  Gabay C, Kushner I. Acute-phase proteins and other systemic   subset upon liver injury promotes hepatic fibrosis.
               responses to inflammation. N Engl J Med. 1999;340(6):448-454.   Hepatology. 2009;50:261-274.
               Erratum in: N Engl J Med. 1999;340(17):1376.
                                                                  doi: 10.1002/hep.22950
               doi: 10.1056/NEJM199902113400607
                                                               51.  Seki E, de Minicis S, Inokuchi S,  et al. CCR2 promotes
            39.  Inatsu A, Kinoshita M, Nakashima H,  et al. Novel   hepatic fibrosis in mice. Hepatology. 2009;50:185-197.
               mechanism of C-reactive protein for enhancing mouse liver
               innate immunity. Hepatology. 2009;49(6):2044-2054.     doi: 10.1002/hep.22952
               doi: 10.1002/hep.22888                          52.  Marra  F,  Tacke  F.  Roles  for  chemokines  in  liver  disease.
                                                                  Gastroenterology. 2014;147:577-594.e1.
            40.  Mihm S. Danger-Associated Molecular Patterns (DAMPs):
               Molecular triggers for sterile inflammation in the liver. Int J      doi: 10.1053/j.gastro.2014.06.043
               Mol Sci. 2018;19:3104.                          53.  Sahin H, Trautwein C, Wasmuth HE. Functional role of
               doi: 10.3390/ijms19103104                          chemokines in liver disease models. Nat Rev Gastroenterol
                                                                  Hepatol. 2010;7:682-690.
            41.  Scaffidi P, Misteli T, Bianchi ME. Release of chromatin
               protein HMGB1 by necrotic cells triggers inflammation.      doi: 10.1038/nrgastro.2010.168
               Nature. 2002;418:191-195.                       54.  Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis.
               doi: 10.1038/nature00858                           Best Pract Res Clin Gastroenterol. 2011;25:195-206.
            42.  Canbay A, Higuchi H, Bronk SF, Taniai M, Sebo TJ, Gores  GJ.      doi: 10.1016/j.bpg.2011.02.005
               Fas enhances fibrogenesis in the bile duct ligated mouse:   55.  Liu C, Tao Q, Sun M,  et al. Kupffer cells are associated
               A  link between apoptosis and fibrosis.  Gastroenterology.   with apoptosis, inflammation and fibrotic effects in hepatic
               2002;123:1323-1330.                                fibrosis in rats. Lab Invest. 2010;90:1805-1816.
               doi: 10.1053/gast.2002.35953                       doi: 10.1038/labinvest.2010.123
            43.  Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell   56.  Holt AP, Salmon M, Buckley CD, Adams DH. Immune
               activation. Nat Rev Gastroenterol Hepatol. 2017;14:397-411.  interactions in hepatic fibrosis. Clin Liver Dis. 2008;12:861.
               doi: 10.1038/nrgastro.2017.38                      doi: 10.1016/j.cld.2008.07.002
            44.  Roehlen N, Crouchet E, Baumert TF. Liver fibrosis:   57.  Xu L, Liu W, Bai F, et al. Hepatic macrophage as a key player
               Mechanistic concepts and therapeutic perspectives.  Cells.   in fatty liver disease. Front Immunol. 2021;12:708978.
               2020;9(4):875.
                                                                  doi: 10.3389/fimmu.2021.708978
               doi: 10.3390/cells9040875
                                                               58.  Lee WY, Kubes P. Leukocyte adhesion in the liver:
            45.  Friedman SL. Hepatic stellate cells: Protean, multifunctional,   Distinct adhesion paradigm from other organs. J Hepatol.
               and enigmatic cells of the liver. Physiol Rev. 2008;88:125-172.  2008;48:504-512.
               doi: 10.1152/physrev.00013.2007                    doi: 10.1016/j.jhep.2007.12.005


            Volume 3 Issue 3 (2024)                         16                              doi: 10.36922/gpd.3186
   31   32   33   34   35   36   37   38   39   40   41